MedTrace Logo

Ceramic Versus Composite in the Treatment of Posterior Teeth by Inlays or Onlays

NCT01724827 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 355

Last updated 2018-03-13

No results posted yet for this study

Summary

The main purpose of this trial is to determine which material, between ceramic and composite, is best to manufacture dental inlays and onlays in the treatment of moderate dental substance losses, generally due to dental caries. Restorations will be done using direct Computer Assisted Design and Manufacturing (CAD-CAM). Another aim of this study is to determine which factors influence the success of these restorations.

Conditions

  • Dental Caries
  • Inlays

Interventions

DEVICE

ceramic (Empress CAD, Ivoclar Vivadent)

Leucite-reinforced glass ceramic (Empress CAD, Ivoclar Vivadent)

DEVICE

composite (Lava Ultimate, 3M Espe)

Nanohybrid composite resin (Lava Ultimate, 3M Espe)

Sponsors & Collaborators

  • Ministry of Health, France

    collaborator OTHER_GOV

  • Hôpital Charles Foix

    collaborator OTHER

  • Hôtel Dieu - Service d'odontologie (Toulouse)

    collaborator UNKNOWN

  • Dental practitionners

    collaborator UNKNOWN

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • hélène fron chabouis, DDS, MSc · APHP, Hôpital Charles Foix, Service d'odontologie, Ivry-sur-Seine, France ; Faculté de chirurgie dentaire, Service de biomatériaux (URB2i EA4462), Université Paris Descartes, Sorbonne Paris Cité, Montrouge, France.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-13
Primary Completion
2016-09-30
Completion
2017-03-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01724827 on ClinicalTrials.gov